"TEREA Blossom Pearl," a new tobacco stick exclusively for the "IQOS ILUMA" series, to be progressively launched from May 11, 2026

Philip Morris Japan G.K. (Headquarters: Chiyoda-ku, Tokyo; President: Ms. Sherry Goh; hereinafter "PMJ") will progressively launch "TEREA Blossom Pearl," a tobacco stick exclusively for the heated tobacco "IQOS ILUMA" series from "TEREA," starting Monday, May 11, 2026. It will be available at four IQOS Stores nationwide*1, IQOS Shops (at some Yamada Denki and Bic Camera stores, etc.), IQOS Corners (at some Don Quijote group stores, etc.)*1, and tobacco retailers nationwide including convenience stores*2. It will also be launched sequentially from Wednesday, May 13, 2026, via the IQOS Online Store.

With the launch of "TEREA Blossom Pearl," the TEREA product lineup will expand to a total of 27 varieties.

PMJ will continue its efforts to provide products and services that satisfy smokers aged 20 and over, aiming for the realization of a "smoke-free society."

*1 As of April 2026
*2 Delivery and launch dates may vary by store.

"TEREA" New Product Information

The "TEREA" products to be launched this time are as follows:

Other "TEREA" Lineup

The other 26 "TEREA" brands already on sale are as follows:

PMI's Corporate Vision: Global Leader in a "Smoke-Free Society"

Philip Morris International (hereinafter "PMI") is an international consumer goods company committed to evolving its portfolio, including products beyond combustible cigarettes and nicotine, to achieve a "smoke-free society" in the long term. Its current product portfolio primarily consists of combustible cigarettes and smoke-free products. As of December 31, 2025, PMI's smoke-free products are deployed in major cities or nationwide in 106 markets worldwide, with an estimated 43.5 million adult smokers (aged 20 and over in Japan, hereinafter the same) globally using PMI's smoke-free products. The smoke-free products business accounts for approximately 41.5% of PMI's full-year net revenue in 2025.

Since 2008, PMI has invested 16 billion USD in developing, scientifically substantiating, and commercializing innovative smoke-free products for adult smokers who would otherwise continue to smoke, aiming to end the sale of combustible cigarettes. This includes building world-class scientific assessment capabilities, particularly in preclinical systems toxicology, clinical and behavioral research, and post-market surveillance. As a result of rigorous, science-based review, the U.S. Food and Drug Administration (FDA) has authorized the marketing of Swedish Match's General snus and ZYN oral nicotine pouches, as well as certain IQOS devices and tobacco sticks from PMI. These were the first authorizations in their respective categories. Additionally, some IQOS devices and tobacco sticks, along with General snus, were the first to receive FDA authorization as Modified Risk Tobacco Products (MRTPs). With a strong foundation and significant expertise in the life sciences, PMI has a long-term goal of expanding into the wellness sector, aiming to enrich lives through the provision of seamless health experiences.

For more details, please visit PMI's website (www.pmi.com) and PMI Science (www.pmiscience.com).

About PMJ aiming for a "Smoke-Free Society"

Philip Morris Japan (PMJ) is a subsidiary of PMI in Japan. It conducts marketing and sales promotion activities for PMI products sold in Japan. Since starting operations in Japan in 1985, PMJ has continued to expand and grow, employing approximately 1,600 people nationwide and holding about 43% of the Japanese tobacco market share (full-year 2025 financial results), leading the market primarily with heated tobacco products. PMJ is promoting PMI's initiative to achieve a "smoke-free society" here in Japan. For more information on PMJ's efforts to expand "smoke-free" facilities and tourist destinations where only heated tobacco products can be used, please visit the PMJ website: https://www.pmi.com/markets/japan/ja/home